|
JPS63313723A
(ja)
|
1987-06-16 |
1988-12-21 |
Nitto Electric Ind Co Ltd |
外用貼付剤
|
|
US5656286A
(en)
*
|
1988-03-04 |
1997-08-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
|
JP4988080B2
(ja)
*
|
1997-09-05 |
2012-08-01 |
日東電工株式会社 |
経皮吸収型製剤
|
|
ES2252865T3
(es)
|
1997-09-26 |
2006-05-16 |
Noven Pharmaceuticals, Inc. |
Composiciones bioadhesivas y metodos para la administracion topica de agentes activos.
|
|
AU2001292781A1
(en)
*
|
2000-09-19 |
2002-04-02 |
National Starch And Chemical Investment Holding Corporation |
Acryl adhesive useful in transdermal drug delivery systems
|
|
GB2410947B
(en)
|
2004-02-11 |
2008-09-17 |
Cambridge Lab Ltd |
Pharmaceutical compounds
|
|
MX2007004315A
(es)
|
2004-10-08 |
2008-03-11 |
Noven Pharma |
Dispositivo para suministro transdermico de farmaco que incluye un respaldo oclusivo.
|
|
WO2006053067A2
(en)
|
2004-11-09 |
2006-05-18 |
Prestwick Pharmaceuticals, Inc. |
Combination of amantadine and a tetrabenazine compound for treating hyperkinetic disorders
|
|
GB0514501D0
(en)
|
2005-07-14 |
2005-08-24 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
|
US20120208773A1
(en)
|
2008-08-12 |
2012-08-16 |
Valeant International (Barbados) Srl |
Pharmaceutical compositions with tetrabenazine
|
|
GB2462611A
(en)
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
|
CA2736409C
(en)
|
2008-09-18 |
2017-07-11 |
Auspex Pharmaceutical, Inc. |
Benzoquinoline inhibitors of vesicular monoamine transporter 2
|
|
JP2013501810A
(ja)
|
2009-08-12 |
2013-01-17 |
ヴァリーント インターナショナル（バルバドス）エスアールエル |
医薬組成物
|
|
DE102010024105A1
(de)
|
2010-06-17 |
2011-12-22 |
Grünenthal GmbH |
Transdermale Verabreichung von Memantin
|
|
AU2013243461A1
(en)
|
2012-04-04 |
2014-11-06 |
Teva Pharmaceuticals International Gmbh |
Pharmaceutical compositions for combination therapy
|
|
PL2872126T3
(pl)
*
|
2012-07-16 |
2018-06-29 |
Grünenthal GmbH |
Plaster farmaceutyczny do przezskórnego podawania tapentadolu
|
|
WO2014188329A2
(en)
|
2013-05-20 |
2014-11-27 |
Mylan, Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
|
BR112015029920A2
(pt)
|
2013-06-04 |
2017-07-25 |
Lts Lohmann Therapie Systeme Ag |
sistema de administração transdérmica
|
|
CA2936823A1
(en)
|
2014-01-27 |
2015-07-30 |
Auspex Pharmaceuticals, Inc. |
Benzoquinoline inhibitors of vesicular monoamine transporter 2
|
|
CA2938581C
(en)
|
2014-02-07 |
2023-02-28 |
Neurocrine Biosciences, Inc. |
Pharmaceutical compositions comprising an antipsychotic drug and a vmat2 inhibitor and uses thereof
|
|
HUE057839T2
(hu)
|
2014-05-06 |
2022-06-28 |
Neurocrine Biosciences Inc |
Valbenazin adagolási rendje hiperkinetikus mozgás-zavarok kezelésére
|
|
AR098771A1
(es)
*
|
2014-12-16 |
2016-06-15 |
Amarin Tech S A |
Un dispositivo para la administración transdérmica de rotigotina
|
|
CN114767672A
(zh)
|
2015-03-06 |
2022-07-22 |
奥斯拜客斯制药有限公司 |
氘代丁苯那嗪或包含氘代丁苯那嗪的组合物
|
|
WO2016210180A2
(en)
|
2015-06-23 |
2016-12-29 |
Neurocrine Biosciences, Inc. |
Vmat2 inhibitors for treating neurological diseases or disorders
|
|
AU2016288188B2
(en)
|
2015-06-27 |
2021-08-05 |
Shenox Pharmaceuticals, Llc |
Ketamine transdermal delivery system
|
|
CN107028916B
(zh)
*
|
2016-02-04 |
2020-05-12 |
北京泰德制药股份有限公司 |
含有布比卡因或其药用盐的皮肤外用制剂
|
|
ITUB20161016A1
(it)
*
|
2016-02-24 |
2017-08-24 |
Emenem Srl |
Composizioni farmaceutiche o cosmetiche comprendenti un polimero e un promotore di assorbimento per il rilascio controllato di principi attivi
|
|
PL3338768T3
(pl)
|
2016-12-20 |
2020-05-18 |
Lts Lohmann Therapie-Systeme Ag |
Transdermalny system terapeutyczny zawierający asenapinę
|
|
KR20230169457A
(ko)
|
2017-01-27 |
2023-12-15 |
뉴로크린 바이오사이언시즈 인코퍼레이티드 |
특정 vmat2 억제제의 투여 방법
|
|
GB201705304D0
(en)
|
2017-04-01 |
2017-05-17 |
Adeptio Pharmaceuticals Ltd |
Pharmaceutical compositions
|
|
US20190111035A1
(en)
|
2017-04-01 |
2019-04-18 |
Adeptio Pharmaceuticals Limited |
Pharmaceutical compositions
|
|
CA3057543A1
(en)
|
2017-04-01 |
2018-10-04 |
Adeptio Pharmaceuticals Limited |
(+)-alpha-dihydrotetrabenazine for use in the treatment a movement disorder
|
|
US20200179352A1
(en)
|
2017-04-26 |
2020-06-11 |
Neurocrine Biosciences, Inc. |
Use of valbenazine for treating levodopa-induced dyskinesia
|
|
US11179469B2
(en)
*
|
2017-04-28 |
2021-11-23 |
Nitto Denko Corporation |
Transdermal absorption preparation
|
|
EP3664787B1
(en)
|
2017-07-20 |
2022-07-20 |
Neurolixis |
Use of selective serotonin 5-ht1a receptor agonists for treating side-effects of vmat inhibitors
|
|
GB2565049B
(en)
|
2017-07-27 |
2020-06-10 |
Reckitt Benckiser Health Ltd |
A head assembly of a dermaplaning device
|
|
MX2020003421A
(es)
|
2017-10-10 |
2020-07-20 |
Neurocrine Biosciences Inc |
Metodos para la administracion de ciertos inhibidores del transportador vesicular de monoamina 2 (vmat2).
|
|
DK3784237T3
(da)
|
2018-04-25 |
2024-01-08 |
Shinkei Therapeutics Inc |
Indretning til transdermal levering af tetrabenazin
|
|
US20190374521A1
(en)
|
2018-06-10 |
2019-12-12 |
Axsome Therapeutics, Inc. |
Methods of modulating tetrabenazine metabolites plasma levels using bupropion
|
|
EP3806856A1
(en)
|
2018-06-14 |
2021-04-21 |
Neurocrine Biosciences, Inc. |
Vmat2 inhibitor compounds, compositions, and methods relating thereto
|